The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Hepatitis C Study Demonstrates Potential for Therapeutic Vaccine

Back to News Homepage

Next

Government Intervention Requested for Poor HCV Detection and Treatment

Vulnerable Amino Acid May be Hepatitis C's Downfall

November 30, 2009

Print this page

Scientists from Rockefeller University uncover some insights into the Hepatitis C genome that suggests new avenues for weakening this insidious virus.

Multitasking may be Achilles heel for hepatitis C

November 23, 2009

(PhysOrg.com) — Hepatitis C, a formidable virus that affects 130 million people worldwide, is nursing some pretty impressive bruises. By knocking out sections and subsections of one of its proteins, scientists reveal weak spots in the virus’s armor and gain new momentum for developing drug targets for sufferers of the disease.

Despite its tiny genome, the hepatitis C virus packs a mean punch. The virus is a microcosm of efficiency, and each of its amino acids plays multiple roles in its survival and ability to sidestep attack. But new research from Rockefeller University suggests that this fancy footwork and multitasking could be the key to bringing down the virus. The work, which focuses on a once-ignored protein, provides insights on how drug therapy for sufferers of the disease might be improved.

The protein, NS2, which is one of the 10 proteins that make up the hepatitis C virus, gained momentum as a plausible drug target in 2006, when Charles M. Rice, head of the Laboratory of Virology and Infectious Disease, and his team solved the structure of its protease domain.

Continue reading the entire article:
http://www.physorg.com/news178227669.html

No Comments - be the first!
Share
Share

Previous

Hepatitis C Study Demonstrates Potential for Therapeutic Vaccine

Back to News Homepage

Next

Government Intervention Requested for Poor HCV Detection and Treatment

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.